semaglutide gastroparesis class action in west virginia A class-action lawsuit has been filed against CVS Caremark over its decision to stop covering Zepbound, Eli Lilly's blockbuster GLP-1 drug to treat obesity. When the major pharmacy benefit manager informed patients semaglutide vomiting law firm in

Fifteen months after initial therapy, the patients oncologist reported that the patient had no signs of progressive cancer

Looking for an Alternative to Ozempic or Wegovy

Insurers implement strict controls like prior authorization and step therapy to manage these high costs and limit access to only the most clinically severe cases

Post-marketing reports have described rare cases of intestinal obstruction in patients taking GLP-1 receptor agonists, potentially related to severely delayed gastric and intestinal transit [9]

Proper handling, timing, and administration affect outcomes

The rapid increase in the use of these medications has led to supply challenges and resulted in the proliferation of compounded analogs, raising concerns about safety and bioequivalence [45]